GEP20146163B - Process for preparing pharmaceutical compounds and intermediate compounds - Google Patents
Process for preparing pharmaceutical compounds and intermediate compoundsInfo
- Publication number
- GEP20146163B GEP20146163B GEAP201012805A GEAP2010012805A GEP20146163B GE P20146163 B GEP20146163 B GE P20146163B GE AP201012805 A GEAP201012805 A GE AP201012805A GE AP2010012805 A GEAP2010012805 A GE AP2010012805A GE P20146163 B GEP20146163 B GE P20146163B
- Authority
- GE
- Georgia
- Prior art keywords
- compounds
- preparing pharmaceutical
- tieno
- tetrahydro
- intermediate compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 2
- 238000004519 manufacturing process Methods 0.000 title 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract 2
- 239000005465 B01AC22 - Prasugrel Substances 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- DTGLZDAWLRGWQN-UHFFFAOYSA-N prasugrel Chemical compound C1CC=2SC(OC(=O)C)=CC=2CN1C(C=1C(=CC=CC=1)F)C(=O)C1CC1 DTGLZDAWLRGWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004197 prasugrel Drugs 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Present invention relates to preparation process of 2-acetoxy-5-(2-fluor-α- cyclopropyl-carbonyl-benzyl)-4,5,6,7-tetrahydro-4H-tieno[3,2-c]pyridine ¬(prasugrel) of formula (I), wherein novel crystalline form of 5-trityl-4,5,6,7-tetrahydro-tieno[3,2-c] pyri¬dine is applied as starting product. 3 dependent
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0900794A HU229031B1 (en) | 2009-12-21 | 2009-12-21 | Process for producing prasurgel and its intermediate |
Publications (1)
Publication Number | Publication Date |
---|---|
GEP20146163B true GEP20146163B (en) | 2014-09-10 |
Family
ID=89989451
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GEAP201012805A GEP20146163B (en) | 2009-12-21 | 2010-12-21 | Process for preparing pharmaceutical compounds and intermediate compounds |
Country Status (8)
Country | Link |
---|---|
US (1) | US9169265B2 (en) |
EP (1) | EP2516447A1 (en) |
BR (1) | BR112012015233A2 (en) |
EA (1) | EA023057B1 (en) |
GE (1) | GEP20146163B (en) |
HU (1) | HU229031B1 (en) |
UA (1) | UA110608C2 (en) |
WO (1) | WO2011077174A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102775422B (en) * | 2012-03-13 | 2014-12-31 | 山东新华制药股份有限公司 | Crystal form of Prasugrel intermediate |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2576901B1 (en) | 1985-01-31 | 1987-03-20 | Sanofi Sa | NOVEL DERIVATIVES OF A- (OXO-2 HEXAHYDRO-2,4,5,6,7,7A THIENO (3,2-C) PYRIDYL-5) ACETIC PHENYL, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION |
FI101150B (en) | 1991-09-09 | 1998-04-30 | Sankyo Co | Process for the preparation of tetrahydrothione nopyridine derivatives useful as a drug |
JP3840662B2 (en) | 1994-10-07 | 2006-11-01 | 宇部興産株式会社 | 2-silyloxy-tetrahydrothienopyridines, salts thereof and process for producing the same |
RU2161282C1 (en) | 1999-05-13 | 2000-12-27 | Багнюков Сергей Анатольевич | Gas cylinder and method for charging it |
CN101460154B (en) | 2006-04-04 | 2015-07-01 | Kg艾克维泽生公司 | Oral dosage forms including an antiplatelet agent and an acid inhibitor |
TWI392681B (en) | 2006-04-06 | 2013-04-11 | Daiichi Sankyo Co Ltd | Prasugrel with high purity and a method for preparing its acid addition salt |
JP2007303860A (en) | 2006-05-09 | 2007-11-22 | Fujikura Ltd | Magnetic device |
DK2123656T3 (en) | 2007-03-02 | 2014-09-08 | Daiichi Sankyo Co Ltd | PROCEDURE FOR PREPARING HIGH PURITY PRASUGREL HYDROCHLORIDE |
CZ302135B6 (en) | 2007-07-09 | 2010-11-10 | Zentiva, A. S. | Process for preparing 5-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4, 5, 6, 7-tetrahydrothieno[3,2-c]-pyridin-2-yl acetate (prasugrel) |
EP2205611A4 (en) * | 2007-11-09 | 2012-02-22 | Reddys Lab Ltd Dr | Processes for the preparation of prasugrel, and its salts and polymorphs |
WO2009066326A2 (en) | 2007-11-19 | 2009-05-28 | Msn Laboratories Limited | Improved process for the preparation of prasugrel and its pharmaceutically acceptable salts |
CN101177430A (en) * | 2007-12-11 | 2008-05-14 | 鲁南制药集团股份有限公司 | Hydrogenated pyridine derivative and method for preparing salt thereof |
CN101245072B (en) | 2008-03-21 | 2011-03-30 | 上海医药工业研究院 | Intermediate for producing prasugrel and producing method thereof |
CN101245073B (en) | 2008-03-21 | 2011-03-23 | 上海医药工业研究院 | Medicine intermediate and preparation method thereof |
CN101250192B (en) | 2008-03-24 | 2010-08-11 | 上海医药工业研究院 | Method for preparing 5-(alpha-cyclopropyl carbonyl-2-fluorobenzyl)-2-oxo-2,4,5,6,7,7a-hexahydrothiophene [3,2-c] pyridine |
CN101250193B (en) | 2008-03-28 | 2010-09-08 | 上海医药工业研究院 | Method for preparing 2-methoxy-5-(alpha-cyclopropyl carbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothiophene [3,2-c] pyridine |
-
2009
- 2009-12-21 HU HU0900794A patent/HU229031B1/en not_active IP Right Cessation
-
2010
- 2010-12-21 WO PCT/HU2010/000149 patent/WO2011077174A1/en active Application Filing
- 2010-12-21 EP EP10807645A patent/EP2516447A1/en not_active Withdrawn
- 2010-12-21 EA EA201290535A patent/EA023057B1/en not_active IP Right Cessation
- 2010-12-21 US US13/517,397 patent/US9169265B2/en not_active Expired - Fee Related
- 2010-12-21 UA UAA201208764A patent/UA110608C2/en unknown
- 2010-12-21 GE GEAP201012805A patent/GEP20146163B/en unknown
- 2010-12-21 BR BR112012015233A patent/BR112012015233A2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
UA110608C2 (en) | 2016-01-25 |
WO2011077174A1 (en) | 2011-06-30 |
HU229031B1 (en) | 2013-07-29 |
EA201290535A1 (en) | 2013-05-30 |
US9169265B2 (en) | 2015-10-27 |
BR112012015233A2 (en) | 2015-09-22 |
EA023057B1 (en) | 2016-04-29 |
HU0900794D0 (en) | 2010-03-01 |
US20120330018A1 (en) | 2012-12-27 |
HUP0900794A2 (en) | 2011-10-28 |
EP2516447A1 (en) | 2012-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010008638A (en) | Furo-and thieno[3,2-c] pyridines. | |
MX2012013082A (en) | 2 -aminopyridine derivatives useful as inhibitors of atr kinase. | |
JO3107B1 (en) | Process for preparing methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate and its purification for use as pharmaceutically active compound | |
MX343274B (en) | Inhibitors of hiv replication. | |
MX356401B (en) | Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (trk) inhibitors. | |
WO2009066775A1 (en) | Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same | |
EP2240464A4 (en) | Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds | |
SG179207A1 (en) | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | |
SG179206A1 (en) | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | |
AU2010246749A8 (en) | Thiophene derivatives | |
AU2012204982A8 (en) | 2,4-diamino-6,7-dihydro-5H-pyrrolo[2,3]pyrimidine derivatives as FAK/Pyk2 inhibitors | |
NZ605234A (en) | Process for the synthesis of substituted morphinans | |
MX348635B (en) | Process for the preparation of pyrazole carboxylic acid derivatives. | |
WO2011042860A3 (en) | New derivatives of thieno[2,3-b]pyridine and 5,6,7,8-tetrahydrothieno[2,3-b]quinoline in particular useful in the treatment of malaria | |
MX2008001018A (en) | N(arylalkyl)-1h-pyrrolopyridine-2-carboxamide derivatives, preparation and therapeutic use thereof. | |
MX2012002369A (en) | Anhydrate forms of a pyridine derivative. | |
WO2011004387A3 (en) | Process for the preparation of dexlansoprazole polymorphic forms | |
GEP20146163B (en) | Process for preparing pharmaceutical compounds and intermediate compounds | |
MX2012004074A (en) | Fused thiazolo and oxazolo pyrimidinones. | |
NZ601998A (en) | Substituted aza-bicyclic imidazole derivatives useful as trpm8 receptor modulators | |
WO2009116072A3 (en) | Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates | |
WO2011051960A3 (en) | Process for producing rapamycin derivatives | |
WO2010146595A3 (en) | Novel polymorphs of flibanserin hydrochloride | |
MX365934B (en) | Carboxylic acid derivatives having an oxazolo[5,4-d]pyridine ring. | |
EA201390016A1 (en) | METHOD FOR PRODUCING PIRANO DERIVATIVES [2,3-C] PYRIDINE |